Analystreport

ProQR Therapeutics N.V. (NASDAQ: PRQR) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

ProQR Therapeutics N.V. - Ordinary Shares  (PRQR) 
Last proqr therapeutics n.v. - ordinary shares earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: proqr.com